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The ability of several different influenza A virus strains to infect and replicate in primary, differentiated airway epithelial cell cultures from
Syrian golden hamsters was investigated. All virus strains tested replicated equivalently in the cultures and displayed a preference for infecting
nonciliated cells. This tropism correlated with the expression of both α2,3- and α2,6-linked sialic acid on the nonciliated cells. In contrast, the
ciliated cells did not have detectable α2,6-linked sialic acid and expressed only low amounts of α2,3-linked sialic acid. In contrast to clinical
isolates, laboratory strains of influenza A virus infected a limited number of ciliated cells at late times post-infection. The presence of α2,3- and
α2,6-linked sialic acid residues on the same cell type suggests that Syrian golden hamsters and differentiated airway epithelial cell cultures derived
from hamsters may provide a system for studying the reassortment of influenza A virus strains which utilize different forms of sialic acid as a
primary virus receptor.
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Influenza virus infection is estimated to be responsible for
approximately 36,000 deaths and 100,000 hospitalizations
annually in the United States alone (Thompson et al., 2003,
2004). These numbers would increase considerably in the event
of an influenza pandemic, which would result from the
introduction of an influenza A virus strain encoding a
hemagglutinin (HA) gene that was not present in viruses
circulating recently in the human population (Barnett et al.,
2005; Bartlett and Hayden, 2005; Wilson et al., 2005).
Pandemic influenza A virus strains are generated through one
of two mechanisms: reassortment or adaptation. Since the
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doi:10.1016/j.virol.2006.06.024segments (Lamb and Krug, 2001), infection of one cell with two
influenza A virus strains can lead to the exchange of genetic
material, a process called reassortment, resulting in a new virus
strain possessing biological properties derived from either
parental viruses (Horimoto and Kawaoka, 2005). The presence
of influenza A virus strains bearing various combinations of the
16 HA and 9 neuraminidase (NA) serotypes in a range of animal
reservoirs provides a pool of virus strains that could be the
source of the next influenza pandemic (Fouchier et al., 2005;
Rohm et al., 1996; WHO, 1980). The influenza pandemics of
1957 and 1968 resulted from reassortment of human and avian
influenza A viruses (Webster et al., 1997). In contrast, the
influenza pandemic of 1918 is believed to have been caused by
an avian influenza A virus which acquired the ability to infect
and efficiently spread in the human population through
adaptation, not reassortment (Reid et al., 2004; Taubenberger
et al., 2005; Tumpey et al., 2005).
The primary, but certainly not the only, hurdle influenza A
virus must overcome when crossing a species barrier is believed
Fig. 1. Influenza A virus replicates in hamster TEC cultures. (A) Recombi-
nant viruses rWSN and rUdorn and (B) clinical isolates A/California/7/2004,
A/Memphis/14/96, and A/Memphis/5/98 were used to infect hamster TEC
cultures at day 10 ALI with an MOI of 3. Infectious virus titers were determined
at the indicated days. Virus titers from the apical chamber are shown as no
infectious virus was detected in the basolateral chamber. The titer of the input
virus is graphed at time=0 and the 1 hr time point represents the initial inoculum
that was remaining after washing. The horizontal, dashed line indicates the limit
of detection, 2000 PFU/mL.
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virus uses sialic acid (SA) residues present at the terminus of
oligosaccharide modifications of host cell glycoproteins as
attachment receptors (Chu and Whittaker, 2004). SA residues
are usually linked to the penultimate carbohydrate group via
α2,3-, α2,6-, or α2,8-linkages, and most influenza A virus
strains characterized to date utilize either α2,3- or α2,6-SA as a
primary receptor (Glaser et al., 2005; Matrosovich et al., 2000).
Avian influenza A virus strains preferentially bind to α2,3-SA
since this form of SA is abundant in the gastrointestinal tract of
various avian species (Gambaryan et al., 2002, 2004; Kim et al.,
2005; Matrosovich et al., 2000). However, while the human
respiratory tract contains both α2,3- and α2,6-SA (Matrosovich
et al., 2004; Shinya et al., 2006; Slepushkin et al., 2001; van
Riel et al., 2006; Zhang et al., 2005), most human influenza A
virus strains show a binding preference for α2,6-SA as a
receptor (Baum and Paulson, 1990; Gagneux et al., 2003;
Matrosovich et al., 2000, 02004).
In mammals, the primary tissues infected by influenza A
virus are the trachea as well as the upper and lower bronchial
tubes (Zambon, 2001). In rare cases, virus infection of the
alveolar epithelial cells occurs, leading to viral pneumonia.
Several animal models have been used to study influenza A
virus pathogenesis, most notably the laboratory mouse (Lu et
al., 1999; Novak et al., 1993). However, most human influenza
A virus strains must be adapted for efficient replication in mice
(Brown et al., 2001; Lu et al., 1999). Human influenza A virus
clinical isolates replicate and cause disease in ferrets
(Govorkova et al., 2005; Herlocher et al., 2001; Maher and
DeStefano, 2004; Reuman et al., 1989; Sweet et al., 2002;
Zitzow et al., 2002), Syrian golden hamsters (Ali et al., 1982;
Daly et al., 2003; Murphy et al., 1997; Potter and Jennings,
1976; Renis, 1977; Snyder et al., 1989; Stein-Streilein and
Guffee, 1986), cotton rats (Ottolini et al., 2005) and non-
human primates (Rimmelzwaan et al., 2001), but with the
possible exception of ferrets, none of these animal models is
used extensively.
Since Syrian golden hamsters can be infected with influenza
A virus and infected hamsters can transmit virus to uninfected
animals, we characterized the ability of influenza Avirus strains
to infect primary, differentiated trachea epithelial cell (TEC)
cultures derived from Syrian golden hamsters. Our results
demonstrate that Syrian golden hamsters and hamster TECs
represent an attractive system for studying infection of
nonciliated airway epithelial cells, investigating the reassort-
ment of influenza Avirus strains which have dissimilar receptor
preferences and generating influenza Avirus strains with altered
or expanded receptor utilization.
Results
Hamster TECs support influenza A virus replication
The ability of influenza A viruses to replicate in well-
differentiated hamster TEC cultures grown in Transwell tissue
culture inserts was determined by infecting the cultures with
recombinant influenza A virus strains A/WSN/33 (rWSN;H1N1) and A/Udorn/72 (rUdorn;H3N2), and the clinical
isolates A/California/7/2004 (H3N2), A/Memphis/14/96
(H1N1) and A/Memphis/5/98 (H3N2). Infectious virus titers
in the supernatants of virus-infected cells were determined by
plaque assay at various times post-infection. Hamster TEC
cultures are routinely infected between days 10 and 14 after
initiation of an air liquid interface (ALI), a time when the culture
is fully differentiated into a polarized, heterogeneous cell
population (Rowe et al., 2004). Both recombinant strains and
clinical isolates displayed similar patterns of replication,
consisting of a peak in viral titer at 1 to 2 days post-infection,
and then a decline to undetectable amounts by 4 to 5 days post-
infection (Figs. 1A, B). Virus was detected in the apical but not
the basolateral supernatants over the time course of infection
(Rowe and Pekosz, 2006), and proteases produced by the cells
were responsible for cleavage of the HA protein into its active
subunits (Rowe et al., 2004). Thus, laboratory strains and
clinical isolates of influenza A virus replicate to equivalent
infectious virus titers in hamster TECs.
The cell tropism associated with influenza A virus infection
was determined by immunostaining virus-infected hamster TEC
cultures for expression of the influenza A virus HA protein and
82 C.M. Newby et al. / Virology 354 (2006) 80–90the ciliated cell marker β-tubulin IVafter infection with rUdorn.
Viral antigen expression correlated with the peak of virus titer,
with antigen-positive cells being abundant at day 1 and
decreasing in subsequent days post-infection (Fig. 2). Viral
antigen appeared to predominate in the nonciliated cell
population, particularly on day 1 post-infection, but limited
numbers of viral antigen-positive, ciliated cells could be
detected at day 2 post-infection. The decreased numbers of
cell nuclei (visualized by TO-PRO-3 fluorescence) over time
(Fig. 2, lower panels) suggested that virus infection induced cell
death within the culture, most likely in the virus-infected cell
population. However, virus infection did not result in death of
all the cells in the culture, as demonstrated by the presence of
ciliated cells at all times post-infection (Fig. 2, upper panels).
These data demonstrate that the nonciliated cells in the hamster
TEC cultures, are the primary cell type infected by rUdorn virus
and that some subset of cells in the cultures are unable to
support influenza A virus replication.
Expression of α2,3- and α2,6-linked SA in hamster TECs
Since influenza viral antigen expression was detected
predominantly in the nonciliated cell population, we determined
whether virus receptor expression could be responsible for the
cell type-specific infection pattern. The expression of α2,3- and
α2,6-linked SAs, the primary receptors for influenza A virus
entry, was determined using lectins that recognize either α2,3-
(Maackia amurensis agglutinin, MAA) or α2,6- (Sambucus
nigra agglutinin, SNA) SA. Both α2,3- and α2,6-SA moieties
were expressed (Fig. 3A), and quantitation of the number of
cells per field expressing each linkage gave a ratio of 1.5:1 of
α2,3- to α2,6-SA expressing cells (Fig. 3B). We next
determined the distribution of α2,3- and α2,6-SA on specific
cell types within the hamster TEC culture. α2,6-SA was
localized to nonciliated cells, as demonstrated by the lack of
colocalization of SNA with the ciliated cell marker protein β-
tubulin IV (Fig. 3C, upper panels). α2,3-SA had a broader
distribution than α2,6-SA, and was detected on both ciliated
and nonciliated cells (Fig. 3C, lower panels). It is important to
note, however, that the population of cells that expressed theFig. 2. Influenza Avirus infection of hamster TECs is self-limiting and specific for a s
of 3, and monitored over 6 days for expression of viral antigen (HA, red) and β-tubu
panel). All images were taken at a 63× magnification.highest levels of α2,3-SA were not β-tubulin IV positive (Fig.
3C, lower panels, white asterisks). Thus, the nonciliated cell
population expressed both α2,3- and α2,6- linked SAs while the
ciliated cells only express α2,3-SA but to a lower level than that
observed on nonciliated cells.
rUdorn viral antigen was detected primarily in nonciliated
cells at day 1 post-infection (Fig. 2), and this correlates with the
high level of α2,3- and α2,6-linked SA expression in the same
population of cells. To conduct a more thorough analysis of
virus strain-specific differences in cell tropism, hamster TECs
were infected with rWSN (H1N1) or rUdorn (H3N2), and viral
antigen expression was analyzed during the first replication
cycle (6 h post-infection), as well as 1 and 2 days post-infection.
The rWSN virus has been passaged extensively in mice and
embryonated eggs, conditions that have been shown to result in
a preference for α2,3-SA as an entry receptor (Gambaryan et al.,
1997, 1999; Matrosovich et al., 2000) and it encodes amino
acids at positions 190 and 225 of the HA protein that dictate
preferred binding to α2,3-SA (Glaser et al., 2005; Stevens et al.,
2006). The rUdorn virus has been passaged in MDCK cells and
MDCK cell passage is believed to maintain the α2,6-linked SA
receptor preference of human influenza A virus strains
(Gambaryan et al., 1997, 1999; Matrosovich et al., 2000). The
amino acids present at positions 226 and 228 of the HA protein
predict a preference for binding to α2,6 SA (Connor et al., 1994;
Gambaryan et al., 1997, 1999, 2005; Govorkova et al., 1999; Ito
et al., 1997; Rogers and Paulson, 1983; Rogers et al., 1983;
Stevens et al., 2006); however, binding of rUdorn HA to α2,3
and α2,6-linked SA was detected using ganglioside binding
assays (Ryan-Poirier et al., 1998).
At 6 h post-infection, rUdorn HA was expressed predomi-
nantly in the nonciliated cell population (Fig. 4A, a–c), and this
same pattern is seen at day 1 post-infection (Fig. 4A, e–g). At
day 2 post-infection, few viral antigen-positive cells are
detected (Fig. 4A, i–k, white asterisks in k denote antigen-
positive cells), suggesting that most of the virus-infected cells
have succumbed to infection. Interestingly, almost all the
antigen-positive cells detected at day 2 post-infection are
ciliated. The numbers of viral antigen-positive cells were
quantified on days 1 and 2 post-infection and data indicate thatubset of cells. Hamster TECs were infected at day 10 ALI with rUdorn at an MOI
lin IV (green). Cell nuclei were visualized with TO-PRO-3 fluorescence (bottom
Fig. 3. The α2,3- and α2,6-linked forms of SA are expressed in hamster TEC
cultures. (A) Representative image showing the distribution of α2,3- or α2,6-
SA. (B) Quantitation of the number of cells per field expressing α2,3- or α2,6-
SA. Each point represents an individual field. (C) The expression of α2,3- or
α2,6-SA (green) compared to the ciliated cell marker β-tubulin IV (red). There
is a low level α2,3-SA expressed in ciliated cells as compared to nonciliated
cells but α2,6-SA appears to be expressed exclusively in nonciliated cells. All
images were taken at a 63× magnification.
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cells on both days post-infection (Fig. 4B). However, the
majority of infected cells are not ciliated and the numbers of
infected, nonciliated cells drop dramatically between days 1 and
2 post-infection. The numbers of ciliated cells in the infected
cultures did not drop as significantly as the total number of
nuclei, indicating that virus infection was eliminating non-
ciliated cells, consistent with the cell tropism data (Fig. 4C).These data indicate that the primary cell type infected by rUdorn
is the nonciliated cell, with some infected ciliated cells detected
at days 1 and 2 post-infection. Since only α2,3-SA is detected in
ciliated cells, the rUdorn virus is most likely utilizing this form
of sialic acid to enter ciliated cells.
The Clara cell secretory protein (CCSP) was used as a
marker for one type of nonciliated cell present in the hamster
TEC cultures (Singh and Katyal, 2000). CCSP colocalized with
rUdorn HA at 6 h post-infection (Fig. 4D, a–c), indicating that
Clara cells are at least one type of nonciliated cell infected by
influenza A virus. At day 1 post-infection, rUdorn HA
expression was clearly detected (Fig. 4D, f), but the CCSP
staining appeared slightly diminished, likely due to the
cytopathic effects of virus replication on this cell type or to
reduced translation of host cell proteins in virus-infected cells
(Fig. 4D, e and g). Expression of α2,6-SA was evident at 6 h
post-infection, but difficult to detect at day 1 post-infection (Fig.
4D, d and h) most likely due to the combined effect of death of
the nonciliated cells and reduced SA expression due to the
activity of the viral NA protein.
Viral antigen expression in rWSN-infected cells was similar
to that of rUdorn at 6 h and day 1 post-infection, with HA
detected predominantly in nonciliated cells (Fig. 4E, a–c and
e–g). At day 2 post-infection, rWSN HA was detected in a
limited number of ciliated cells; however, antigen-positive
nonciliated cells were also present (Fig. 4E, i–k, ciliated cells
marked with asterisks). The numbers of antigen-positive cells
were quantified and the data again show that the nonciliated
cells are the primary cell type infected by rWSN, with infected
ciliated cells low in number (less than 5%) at days 1 and 2 post-
infection (Fig. 4F). The reduction in number of nuclei per field
was much greater than the reduction of ciliated cells per field,
indicating that the nonciliated cells were preferentially
eliminated in virus-infected monolayers (Fig. 4G). When the
expression of α2,3-SA – the SA form expressed on ciliated
cells – was assessed, the ciliated cells infected at day 2 showed
reduced amounts of α2,3-SA when compared to nonciliated
cells at 6 h or 1 day after infection (Fig. 4E, panels d, h, and l).
These data suggest that rWSN infects primarily nonciliated
cells, with limited numbers of ciliated cells infected at days 1
and 2 post-infection. Taken together, the data in Fig. 4 indicate
that the expression of α2,3- and α2,6-SA on nonciliated cells
correlates very closely with the predominant viral antigen
expression at early and late times during infection with both
rUdorn and rWSN viruses.
In addition to rWSN and rUdorn, clinical isolates A/
California/7/2004, A/Memphis/14/96, and A/Memphis/5/98
were also examined for HA expression in the hamster TEC
cultures at the same time points (Fig. 5). The A/Memphis/14/96
and A/Memphis/5/98 viruses have been documented to bind
preferentially to α2,6-SA (Matrosovich et al., 2003, 2004). HA
expression of all three clinical isolates displayed the same
antigen pattern—expression of HA exclusively in the non-
ciliated cells during the first round of virus replication (Fig. 5A,
a–c, e–g, i–k) and day 1, with little to no antigen detected at day
2. The number of antigen-positive cells, ciliated cells, and
nuclei at day 1 and day 2 were quantified for each clinical
Fig. 4. InfluenzaAvirus infection targets nonciliated cells in hamster TEC cultures. Cultures were infectedwith anMOI of 3, andwere analyzed for antigen expression at
the indicated times post-infection (A) rUdorn HA expression (red) compared to β−tubulin IV (green) (D) Colocalization of rUdorn HA (blue) with the secretory cell
protein CCSP (red) and α2,6-SA (E) rWSN HA expression (red) compared to β−tubulin IV (blue) and α2,3-SA. White asterisks in panels A-k and E-k indicate virus-
infected ciliated cells at day 2 post-infection. The same field is shown in each of the four panels for each row. Quantitation of antigen-positive cells (B, F) and ciliated
cells and nuclei (C, G) at days 1 and 2 post-infection. Ten to fourteen fields were counted for each virus per day and the data are expressed as a percentage of the total cells
(nuclei) present in each field. There are approximately 150–250 nuclei per field in uninfected cultures (Rowe et al., 2004). All images were taken at a 63×magnification.
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Fig. 5. Influenza A virus clinical isolates exclusively target nonciliated cells in hamster TEC cultures. Cultures were infected with an MOI of 3 and were analyzed for
antigen expression at indicated times post-infection. (A) Clinical isolates A/California/7/2004, A/Memphis/5/98, and A/Memphis/14/96 at 9 h post-infection. HA
expression (red) compared to β−tubulin IV (green). The same field is shown in each of the four panels for each row. (B–G) Quantitation of antigen-positive cells (B, D,
and F) and ciliated cells and nuclei (C, E, and G) at days 1 and 2 post-infection. Ten to fourteen fields were counted for each virus per day and the data are expressed as
a percentage of the total cells (nuclei) present in each field. There are approximately 150–250 nuclei per field in uninfected cultures (Rowe et al., 2004). All images
were taken at a 63× magnification.
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relatively constant through 2 days post-infection, nuclei counts
decrease, suggesting again that the nonciliated cell population is
infected and eliminated after infection with influenza A virus
(Figs. 5C, E, and G). However, in contrast to the laboratory
strains, antigen-positive ciliated cells were not detected at any
time point with the three clinical isolates (Figs. 5B, D, and F).
Thus, it appears that the ability of rWSN and rUdorn to infect a
limited number of ciliated cells is not shared by the clinical
isolates of the influenza A virus strains analyzed, and may be
related to altered SA receptor usage (Deom et al., 1986; Ohuchi
et al., 1997; Ward, 1997), or that tissue culture passage has
created minor populations able to bind to alternate receptors in
the case of rUdorn. Clinical human isolates of influenza Avirus,
however, seem to maintain a more strict receptor specificity for
the α2,6-SA expressing nonciliated cell population.
Discussion
Receptor utilization is an important determinant of viral
pathogenesis and cell tropism. For influenza A virus, receptor
utilization is particularly important as it is thought to be one of
the key factors enabling avian influenza A viruses to replicate
in and spread between humans (Parrish and Kawaoka, 2005).
The ongoing outbreak of H5N1 virus occurring in poultry
throughout Asia and parts of Europe has led to over 100 cases
of human infection, thus increasing the likelihood that a variant
of H5N1 displaying an expanded receptor tropism for α2,6-SA
may emerge (Bartlett and Hayden, 2005; Holmes et al., 2005).
In order to better understand the process that can lead to the
emergence of a pandemic influenza virus strain, appropriate
animal and tissue culture models must be developed. Our data
with Syrian golden hamster airway epithelial cell cultures
provides such a model system.
Hamster TECs are susceptible to lab adapted as well as
clinical isolates of influenza A virus (this study and (Rowe and
Pekosz, 2006), and Syrian golden hamsters have been shown to
be an animal model for influenza A virus infection (Ali et al.,
1982; Potter and Jennings, 1976; Renis, 1977; Stein-Streilein
and Guffee, 1986). Murine tracheal tissues and TEC cultures
contain α2,3-SA on ciliated cells and little to no detectable
α2,6-SA (CMN and AP unpublished observations) perhaps
explaining the poor ability of human influenza Avirus strains to
replicate and cause disease in mice. Since hamster airway
epithelial cells possess both α2,3- and α2,6-SA receptors, they
are suitable hosts for comparative studies between viruses
displaying different SA receptor specificities, avian and human
influenza viruses for example. Syrian golden hamsters have
been shown to support the replication of equine influenza A
virus strains (Daly et al., 2003) and these influenza A virus
strains have a preference for utilizing α2,3-SA as a receptor
(Medeiros et al., 2004) due to the prevalence of α2,3-SA in the
equine respiratory tract (Lin et al., 2001).
Since both forms of SA were present in the same cell type,
primarily nonciliated cells, hamster TEC cultures may facilitate
studies on the reassortment between influenza A viruses which
utilize different forms of SA (avian and human influenzaviruses for example) as well as the adaptation of α2,3-SA
utilizing viruses to α2,6-SA usage. The expression of α2,3-SA
in ciliated cells was reduced when compared to expression in
nonciliated cells, and ciliated cells were less susceptible to
infection with rUdorn and rWSN. This may indicate that the
absolute level of SA on the plasma membrane may also dictate
the susceptibility of a cell to influenza A virus infection, but
definitive statements on this await more careful and accurate
quantification of SA levels in specific cell types. The effect of
viral neuraminidase activity and specificity on the amount of
available SA may also have a profound effect on cell suscep-
tibility to virus infection.
The expanded cell tropism of rUdorn in hamster TEC
cultures when compared to primary influenza A virus isolates
may reflect the ability of the Udorn HA protein to recognize
both α2,3- and α2,6-SA (Ryan-Poirier et al., 1998). Curiously,
the Udorn HA protein possesses amino acid residues at
positions 193, 226, and 228 that are found in H3 subtype
viruses that bind preferentially to α2,6-SA (Medeiros et al.,
2001, 2004; Stevens et al., 2006; van Riel et al., 2006). Position
186 of H3 subtype HA proteins has been implicated in altered
receptor specificity with substitutions of G186V or S186I
resulting in increased α2,3-SA binding (Gambaryan et al.,
1999; Widjaja et al., 2006); however, the rUdorn strain encodes
an S at this amino acid. This indicates that other, as yet
unidentified amino acids may alter SA receptor recognition in
H3 subtype HA proteins or that the assays used to detect α2,3-
and α2,6-SA binding are not reflective of the cell tropism
documented in this study. It is important to note that while
receptor utilization and expression are important determinants
of influenza A virus cell tropism in the respiratory tract
(Matrosovich et al., 2004; Shinya et al., 2006; van Riel et al.,
2006; Zhang et al., 2002, 2005), it has been demonstrated that
interferon and interferon signaling are also important factors
that limit influenza A virus tropism in vivo and in vitro (Garcia-
Sastre et al., 1998a, 1998b).
The expression of α2,3- and α2,6-SA in the human res-
piratory tract has been investigated extensively (Matrosovich et
al., 2004; Slepushkin et al., 2001; Zhang et al., 2005). Most
studies support the model that α2,3-SA is present primarily, if
not exclusively, in the ciliated cells. The expression of α2,6-SA
has been documented to be either exclusively in the nonciliated
cells (Matrosovich et al., 2004) or present in both ciliated and
nonciliated cells (Ibricevic et al., in press; Zhang et al., 2005).
The amount of SA on each cell type has yet to be quantified
precisely. Highly pathogenic H5N1 influenza A virus strains
have limited ability to attach to and replicate in the upper
respiratory tract as compared to the lower respiratory tract—
again the result (at least in part) of altered expression of α2,3-
and α2,6-SA (Shinya et al., 2006; van Riel et al., 2006). The
SA receptor pattern on hamster TEC cultures differs from that
described for humans, an important factor to consider when
interpreting hamster pathogenesis experiments. However, there
are two points to consider when deciding between hamsters or
mice for influenza pathogenesis studies. First, the hamster
model may be better suited to pathogenesis experiments with
human influenza A virus strains when compared to the mouse
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tract, but is present in the upper and lower respiratory tract of
the hamster (CMN and AP unpublished observations). Second,
humans and hamsters have significant numbers of mucous-
secreting goblet cells (Atherton et al., 2003; Rowe et al., 2004)
while mice possess virtually undetectable numbers (Look et al.,
2001; Shahzeidi et al., 2003; Walter et al., 2002). Since hamster
and human goblet cells also express SA receptors, studies on
the effects of influenza on this cell type are best performed in
the hamster model.
It has been suggested that replication of influenza A virus
in nonciliated cells is important for efficient virus replication
and/or transmission in humans (Matrosovich et al., 2004).
This may also explain the ability of hamsters to support the
replication and transmission of human influenza A virus
strains (Ali et al., 1982; Daly et al., 2003) and suggest that
studying transmission of human and avian influenza A viruses
in hamsters may help shed light on viral and host factors that
are important for virus transmission. Our data demonstrate
that primary, differentiated hamster TEC cultures can serve as
a useful model of influenza A virus pathogenesis and cell
tropism, and provide a relevant cell culture system for studying
influenza virus strains that have different SA receptor
specificities.
Materials and methods
Reagents and antibodies
The components in TEC basic media (TEC basic), pro-
liferation media (TEC plus), and maintenance media (TEC
MM) have been described previously (Rowe et al., 2004).
Rabbit anti-hamster Clara cell secretory protein (CCSP; 1:500
immunofluorescence) was kindly provided by Gurmukh Singh
(VA medical center, Pittsburgh, PA). Other primary antibodies
were purchased and used as follows: mouse anti-β Tubulin IV
(1:100 immunofluorescence; BioGenex, San Ramon, CA), goat
anti-H3 hemagglutinin (HA-H3 subtype) Aichi/2/68 sera (1:500
immunofluorescence; NIH/NIAID reference reagent V314-591-
157), goat anti-H1 hemagglutinin (HA-H0 subtype) A/PR8/34
sera (1:500 immunofluorescence; NIH/NIAID reference reagent
V314-511-157). The influenza A virus HA antibodies showed
minimal reactivity to mock-infected hamster TEC cultures (data
not shown). Secondary antibodies were used as follows: donkey
anti-mouse IgG conjugated to fluorescein isothiocyanate (1:250
immunofluorescence), donkey anti-goat IgG conjugated to
rhodamine red (1:250 immunofluorescence), and goat anti-
mouse IgG conjugated to rhodamine red (1:250 immunofluor-
escence) were purchased from Jackson Immunoresearch
(Westgrove, PA); goat anti-mouse IgG conjugated to Alexa
Fluor 647 (1:500 immunofluorescence), donkey anti-mouse
IgG conjugated to Alexa Fluor 647 (1:500 immunofluores-
cence), goat anti-rabbit IgG conjugated to Alexa Fluor 594
(1:500 immunofluorescence), and TO-PRO-3 nuclear stain
(1:500) were purchased from Molecular Probes (Eugene, OR);
anti-digoxigenin-fluoroscein, FAb fragment (1:50) was pur-
chased from Roche applied science (Indianapolis, IN).Cell lines
Madin–Darby canine kidney cells (MDCK American Type
Culture Collection, Manassas, VA) were cultured in Dulbecco's
modified Eagle medium (DMEM, Sigma, St. Louis, MO)
containing 10% fetal bovine serum (Atlanta Biologics, Atlanta,
GA), 100 U/mL of penicillin, and 100 μg/mL of streptomycin
(Invitrogen, Grand Island, NY) and maintained at 37 °C in a
humidified environment containing 5% CO2.
Viruses
Recombinant influenza A viruses A/WSN/33 (rWSN)
(Neumann et al., 1999; Takeda et al., 2002) and A/Udorn/72
(rUdorn) (Takeda et al., 2002), and the influenza Avirus clinical
isolates A/California/7/2004 (H3N2, Centers for Disease
Control, Atlanta GA), A/Memphis/14/96 (H1N1), and A/
Memphis/5/98 (H3N2) (St. Jude Children's Hospital, Memphis,
TN) were used in this study. The latter two virus strains have
been characterized with respect to their cell tropism in human
TEC cultures (Matrosovich et al., 2004) and receptor specificity
(Matrosovich et al., 2003). Virus stocks were generated by
infecting MDCK cells and infectious virus was quantified by
plaque assay using MDCK cells as previously described
(Paterson and Lamb, 1993). The H3 amino acid numbering
system is used when referring to amino acid positions in HA.
Hamster TEC cultures
Hamster TEC isolation and culture conditions were
performed as previously described (Rowe et al., 2004). In all
experiments, hamster TEC cultures were seeded and maintained
in 0.4 μM pore, 0.33 cm2 Transwell–Clear support membrane
(Corning Costar, Corning NY) (Rowe et al., 2004).
Infection of hamster TECs
Hamster TEC cultures were infected between days 10 and
14 after ALI. Hamster TECs were infected via the apical
chamber with 1×106 plaque forming units (pfu) of virus
diluted in warm DMEM with penicillin/streptomycin in a total
volume of 100 μL. If all the cells in the culture were
susceptible to influenza virus infection, this would correspond
to a multiplicity of infection (MOI) of approximately 3. Since
the cultures are psuedostratified, not all of the cells in the
culture will be exposed to the apically administered virus
inoculum. Also, not all cell types express influenza A virus
receptors. Cells were incubated with virus at 37 °C for 1 h,
inoculum removed, and cells washed three times with 200 μL
of warm DMEM with penicillin/streptomycin. After washing,
100 μL of DMEM with penicillin/streptomycin and 500 μL of
TEC maintenance media (MM) (Rowe et al., 2004) were
placed in the apical and basolateral chambers, respectively.
Apical and basolateral supernatants were collected at the
indicated times post-infection and stored at −70 °C. All
growth curves and immunostaining on hamster TEC cultures
were reproduced at least three times.
88 C.M. Newby et al. / Virology 354 (2006) 80–90Immunofluorescence confocal microscopy
At indicated times post-infection, hamster TECs were
washed three times with phosphate buffered saline (PBS,
GIBCO Inc., Carlsbad, CA), and fixed in PBS containing 2%
paraformaldehyde for 15 min at room temperature. Cells were
washed three times and permeabilized with PBS containing
0.2% Triton-X 100 and 0.1% sodium citrate for 10 min at room
temperature. Cells were washed with PBS and incubated in PBS
containing 3% normal goat or normal donkey serum and 0.5%
bovine serum albumin (blocking buffer) for 30 min at room
temperature. Cells were washed and incubated with blocking
buffer containing primary antibodies for 1 h at room
temperature, washed again, and incubated with blocking buffer
containing secondary antibodies and TO-PRO-3 for 45 min.
The wash solution for all steps is PBS with 0.2% Tween-20.
Transwell–Clear membranes were mounted using 10 μL of
ProLong antifade (Molecular Probes), and slides were imaged
using a Ziess LSM 510 Meta confocal microscope. All images
were obtained with a 63× oil objective. All images presented are
a flattened composite of 5–10 micron Z-stack images collected
with LSM software.
Detection of lectin binding
The DIG glycan differentiation kit (Roche, Indianapolis, IN)
was used. SA linked to the penultimate galactose or N-
acetylgalactosamine via an α2,3 linkage was detected with
digoxigenin-conjugated M. amurensis agglutinin (MAA) lectin
while α2,6 linked SA was detected with digoxigenin-conju-
gated S. nigra agglutinin (SNA) lectin. Samples were stained
according to the manufacturer's protocol using anti-digoxigenin
FITC. Lectin-positive cells in 10 to 12 fields were counted to
determine the number of cells expressing each linkage. There
are between 150–250 total cells per field, as determined by TO-
PRO-3 staining. Lectin staining on hamster TEC cultures was
reproduced in three separate experiments.
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